Eurofins expands in India

Acquires biopharmaceutical company Advinus from Tata Group

27-Jul-2017 - Eurofins Scientific announces that it has signed an exclusive agreement with Tata Group to acquire Advinus Therapeutics, a preclinical and clinical phase contract research company for Safety Assessment, DMPK, CMC services, and Analytical R&D Services. The transaction is expected to close in the ...

Rentschler and Leukocare announce strategic alliance and equity investment

06-Feb-2017 - Rentschler Biotechnologie GmbH, Laupheim and Leukocare AG, Martinsried announced a strategic alliance under which Leukocare will become the specialized technology partner and the exclusive formulation developer for Rentschler’s biopharmaceuticals business. Rentschler in return will become the ...

Vetter Starts Operations in Its Center for Visual Inspection and Logistics

Site enlargement enables increased capacity for state-of-the-art quality control and storage

27-Jan-2017 - Vetter, a Contract Development and Manufacturing Organization (CDMO) for development, aseptic filling and final packaging of injectables, has announced that it has begun operations in its expanded Visual Inspection and Logics Center located in Ravensburg. The enlargement, in which the company ...

Pharmaron Acquires Xceleron Inc.

Acquisition expands Pharmaron’s radiolabelled sciences capabilities

12-Jan-2017 - Pharmaron, a fully integrated contract research organization offering R&D services for the life science industry, today announced the acquisition of Xceleron Inc. Xceleron is a Maryland, US-based globally leading Accelerator Mass Spectrometry (AMS) specialist for life sciences. The AMS platform ...

Chemistry CRO YProtech adds High Potency Capabilities

04-Jan-2017 - YProtech, a contract research organisation (CRO) focused on niche chemistry based services, has installed a high potency facility for the synthesis and manufacture of highly potent cytotoxins for applications in cancer treatment. Tom Screen, CTO of YProtech commented, ‘The new facility is now ...

The NUVISAN group acquires a pre-clinical unit in Grafing from Merck

New Managing Director at the Grafing site

01-Jul-2016 - NUVISAN acquires a research and development site in Grafing, Germany from its longstanding partner Merck. With the addition ofpre-clinical DMPK Services from Merck, NUVISAN passes the next phase in its realignment as a pre-clinical and clinical contract research organization (CRO). NUVISAN ...

Parexel launches expanded genomic research services

18-Feb-2016 - Parexel International Corporation announced expanded services and capabilities in genomic-based drug development. The PAREXEL®Genomic Medicine team offers clients a variety of strategic and operational genomic research services to accelerate drug development and to support regulatory and payer ...

KCR Accomplishes ISO 9001:2008 Certification for All Company Services

26-May-2015 - KCR, a Contract Research Organization (CRO), has recently validated the quality and accuracy of its operations receiving ISO 9001:2008 Certification for all its services. The company achieved its first ISO 9001:2008 certification in February 2007, and was recertified in 2010 and 2013. This year ...

Huntingdon Life Sciences Acquires Harlan Laboratories

05-May-2014 - Huntingdon Life Sciences announced that it has acquired Harlan Laboratories. The new company will have two operating divisions: Research Models and Services and Contract Research Services. This acquisition creates a leading global organization offering full service, non-clinical, contract ...

Molecular Imaging, Inc. Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging

16-Dec-2011 - Molecular Imaging, Inc., a specialty contract research organization providing multi-modality preclinical in vivo imaging services to pharmaceutical and biotechnology companies, announced that it has entered into a licensing agreement with Dana-Farber Cancer Institute to access a substantial ...